As pharmaceutical companies push changes to the 340B drug pricing program, safety-net hospitals serving Black and low-income ...
The American Hospital Association (AHA) writes to alert you to the latest development in connection with the growing number ...
Minnesota's Legislature is reckoning with 340B, a prescription medication discount program for nonprofit hospitals, for ...
The Well News on MSNOpinion
The 340B windfall that misses patients
Congress created the 340B drug discount program in 1992 with a simple premise: allow hospitals and federal grantees serving a ...
Congress should restore the 340B program to its original purpose, and New York lawmakers should do what they can not to make ...
The 340B drug plan language that was recently added into Senate Bill 494 risks increasing costs for the very patients it ...
Johnson & Johnson, Eli Lilly, Sanofi and Bristol Myers Squibb are suing the federal government over the future of their 340B drug rebate plans. The lawsuits reflect rising tensions among drugmakers, ...
The federal 340B Drug Pricing Program, which requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to healthcare organizations that care for ...
In our January 14 blog, we explained that Chief Judge Lance Walker of the U.S. District Court for the District of Maine had entered a nationwide preliminary injunction in American Hospital Association ...
Drug manufacturers participating in the Section 340B Drug Pricing Program now face a significant new litigation risk under the False Claims Act (“FCA”). In a recent decision, Adventist Health System v ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results